class="post-template-default single single-post postid-450048 single-format-standard custom-background group-blog header-image full-width singular wpb-js-composer js-comp-ver-6.1 vc_responsive"

Team Jack to Fund Medulloblastoma Research at UNMC Omaha

Team Jack to Fund Medulloblastoma Research at UNMC Omaha
In March of 2020 the Team Jack Foundation announced grant funding for Dr. Sidharth Mahapatra's research project at the University of Nebraska Medical Center in Omaha, Nebraska. Dr. Mahapatra's project is titled chemosensitization of non-SHH/WNT medulloblastoma is regulated by miR-1253. This award is the first from funding raised through Team Jack's Power5 Pediatric Brain Tumor Initiative, which is a pledge to fund $5 million in pediatric brain cancer research over ten years at UNMC.

"Engaging and treating these patients has become a bit of a passion for me because I find them to be the most fragile of patients that I’ve taken care of." .

- Dr. Mahapatra

During a time that is unprecedented in most of our lifetimes, with schedules and routines halted, there is one thing we know for sure that has not stopped. Kids are still getting diagnosed with brain cancer, still receiving treatments and still dying from the disease. In addition to that, researchers continue to forge ahead in discovering new treatments for these kids, even right here in Nebraska.

The Team Jack Foundation is proud to announce a three-year commitment to fund a $330,000 medulloblastoma project. The project is led by Dr. Sidhart Mahapatra at the University of Nebraska Medical Center in Omaha, Nebraska and will focus on medulloblastoma, grades three and four. The project that will study the chemosensitization on non-SHH/WNT medulloblastoma is regulated by miR-1253. Read more information on the project here under Project 7.

“Engaging and treating these patients has become a bit of a passion for me because I find them to be the most fragile of patients that I’ve taken care of,” stated Dr. Mahapatra. “Team Jack now is taking the lead in helping support me for the next few years, in a very critical time, wherein I have discovered certain promising targets and now I need the funding and support to see that through to the next stage,” Mahapatra continued.

In addition to Dr. Mahapatra’s high-risk medulloblastoma project, the Team Jack Foundation also approved funding for Dr. Meaghann Weaver’s RHYTHYM Therapy project as well as a pharmacogenomic screening study to optimize pain medications in pediatric neuro-oncology patients led by Chris Shaffer, PharmD. Stay tuned for more information on these projects.

All three of these research projects are part of the Team Jack’s Power5 Pediatric Brain Tumor Initiative in which the Foundation has pledged a $5 million commitment to fund four areas including Research (Laboratory and/or Clinical), Education and Pain Management in Cancer. For more information about the Power5 program or the Nebraska Brain Tumor Program at UNMC in Omaha, visit www.nebraintumorprogram.org.

While we are so pleased to be funding research at UNMC it is our supporters that need the real pat on the back. Without all of you, these exciting projects would still be on hold and not any closer to helping kids. Thank you for your support and for helping us make child brain cancer a priority.

To make a contribution to the Team Jack Foundation, click here.

 

© 2020 Nebraska Rural Radio Association. All rights reserved. Republishing, rebroadcasting, rewriting, redistributing prohibited. Copyright Information
Share:
Comments